Steve E. Krognes insider trades: Guardant Health (GH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steve reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | GH | ↓ Sell | 6,674 | $175.74 | $1.2M | Direct | Sep 17, 2026 (1d) |
| Jan 7, 2025 | DNLI | ↓ Sell | 3,339 | $20.81 | $69K | Direct | Jan 8, 2025 (1d) |
| Dec 31, 2024 | DNLI | ↓ Sell | 30,000 | $20.25 | $608K | Direct | Jan 3, 2025 (3d) |
| Sep 30, 2024 | DNLI | ↓ Sell | 30,000 | $29.03 | $871K | Direct | Oct 2, 2024 (2d) |
| Aug 20, 2024 | DNLI | ↓ Sell | 1,727 | $23.79 | $41K | Direct | Aug 22, 2024 (2d) |
| Jul 1, 2024 | DNLI | ↓ Sell | 30,688 | $22.11 | $679K | Direct | Jul 3, 2024 (2d) |
| Apr 1, 2024 | DNLI | ↓ Sell | 92,500 | $20.50 | $1.9M | Direct | Apr 2, 2024 (1d) |
| Feb 13, 2024 | DNLI | ↓ Sell | 2,750 | $17.29 | $48K | Direct | Feb 15, 2024 (2d) |
| Jan 5, 2024 | DNLI | ↓ Sell | 3,208 | $19.43 | $62K | Direct | Jan 9, 2024 (4d) |
| Aug 21, 2023 | DNLI | ↓ Sell | 1,419 | $22.60 | $32K | Direct | Aug 23, 2023 (2d) |
| Feb 13, 2023 | DNLI | ↓ Sell | 2,119 | $30.10 | $64K | Direct | Feb 15, 2023 (2d) |
| Feb 8, 2023 | DNLI | ↓ Sell | 1,377 | $30.88 | $43K | Direct | Feb 10, 2023 (2d) |
| Jan 5, 2023 | DNLI | ↓ Sell | 2,970 | $28.44 | $84K | Direct | Jan 9, 2023 (4d) |
| Aug 19, 2022 | DNLI | ↓ Sell | 2,253 | $33.22 | $75K | Direct | Aug 23, 2022 (4d) |
| Feb 11, 2022 | DNLI | ↓ Sell | 2,560 | $34.69 | $89K | Direct | Feb 15, 2022 (4d) |
| Feb 9, 2022 | DNLI | ↓ Sell | 1,296 | $37.09 | $48K | Direct | Feb 11, 2022 (2d) |
| Jan 5, 2022 | DNLI | ↓ Sell | 2,225 | $44.75 | $100K | Direct | Jan 7, 2022 (2d) |
| Aug 19, 2021 | DNLI | ↓ Sell | 2,285 | $49.57 | $113K | Direct | Aug 23, 2021 (4d) |
| Mar 15, 2021 | DNLI | ↓ Sell | 50,000 | $61.89 | $3.1M | Indirect | Mar 16, 2021 (1d) |
| Feb 16, 2021 | DNLI | ↓ Sell | 50,000 | $65.09 | $3.3M | Indirect | Feb 18, 2021 (2d) |
| Feb 11, 2021 | DNLI | ↓ Sell | 3,035 | $70.34 | $213K | Direct | Feb 16, 2021 (5d) |
| Feb 9, 2021 | DNLI | ↓ Sell | 1,448 | $74.68 | $108K | Direct | Feb 11, 2021 (2d) |
| Jan 15, 2021 | DNLI | ↓ Sell | 50,000 | $71.45 | $3.6M | Indirect | Jan 20, 2021 (5d) |
| Mar 30, 2020 | DNLI | ↓ Sell | 1,428 | $19.48 | $28K | Direct | Apr 1, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GH insiders
Open-market trades in the last 12 months
About Steve E. Krognes's insider trades
Steve E. Krognes is a director at Guardant Health (GH). Since Mar 30, 2020, Steve has reported no open-market purchases and 24 sales worth $16.4M on SEC Form 4. In the last 12 months: 1 sale ($1.2M).
Their filings also include option exercises (42 filings), grants and awards (29 filings), shares withheld for taxes (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.